Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. Clin Transpl 1995:117-27
Date
01/01/1995Pubmed ID
8794259Scopus ID
2-s2.0-0029445232 (requires institutional sign-in at Scopus site) 28 CitationsAbstract
Allogeneic and autologous bone marrow and blood cell transplants are increasingly used treatments for cancer and disorders of bone marrow and immune function. This is largely due to use of autotransplants to treat common diseases such as breast cancer. The use of blood cells alone for autotransplants was also a significant change in the past 5 years. The IBMTR and ABMTR continue to provide a unique resource for studying outcomes and trends in allogeneic and autologous bone marrow and blood cell transplants.
Author List
Passweg JR, Rowlings PA, Armitage JO, Gale RP, Pelz CJ, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MMAuthors
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of WisconsinMei-Jie Zhang PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdolescentAdult
Anemia, Aplastic
Bone Marrow Transplantation
Female
Hematopoietic Stem Cell Transplantation
Hodgkin Disease
Humans
International Agencies
Leukemia
Lymphoma, Non-Hodgkin
Male
Middle Aged
North America
Registries
Survival Rate
Transplantation, Autologous
Transplantation, Homologous